In the 2008 WHO classification, the presence of RUNX1::RUNX1T1, CBF::MYH11, PML::RARA alone was sufficient to make a diagnosis of AML (or in the case of the latter, APL), regardless of the blast percentage. This evidence concerns the gene RUNX1T1 and acute myeloid leukemia.